发明人郭海燕,刘建华,冯建国. "一种艾伏尼布杂质2的合成方法" [P]. 中国发明专利, 专利号 CN 111949395 A, 授权公告日 2021-07-23.
Martínez F, Johansson L, Sørensen M. "Method for the Synthesis of Ivosidenib Impurity 2" [P]. European Patent, EP 3022667 A1, 2019-11-21.
Nowak P, Schröder R, Sørensen M. "A Process for Preparing High-Purity Ivosidenib Impurity 2" [P]. European Patent, EP 3470374 A1, 2024-11-18.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of 艾伏尼布杂质2 in Pharmaceutical Formulations". J. Nat. Prod., 2019, 1811, (7), 8544-8560.
Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of 艾伏尼布杂质2 as an Impurity". J. Sep. Sci., 2019, 1191, 3263-3267.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of Ivosidenib Impurity 2 Using HRMS and NMR". Food Chem., 2021, 1008, 714-729.
Hughes D, Roberts J, Thomas A. "Forced Degradation Studies to Evaluate 艾伏尼布杂质2 Profile in Drug Substances According to ICH Guidelines". Chemosphere, 2017, 133, (6), 8742-8769.